![ESMO Asia_poster_02](/var/esmo/storage/images/media/esmo-daily-reporter/images/generic-pictures-live/esmo-asia_poster_02/9569365-1-eng-GB/esmo-asia_poster_02_i770.jpg)
Some practice-changing results in breast cancer are perceived differently in low-resourced countries
Cost, limited drug availability and lack of diagnostic testing facilities are hurdles to adopting practice-changing recommendations in some Asian countries